Day OneMonday, 23 September 2024 - CT (Central Time)

• General metrics, pricing philosophy, interactive learning

• Interaction between IRA and 340B –Internal Education for Partners

Join a Government Contracts expert for insights into legislation pending in Congress and other Government actions that will impact U.S. government contractors and other recipients of Federal funding

• The scope and timing of the proposed prohibitions and their implications for the industry
• Insights on the applicability to the VA FSS, Tricare, 340B, Medicare and Medicaid programs
• Grandfathering provisions, possible waivers, and their limitations
• Best practices and approaches to prepare for the legislation
• Other current and potential future Government actions in this space

• Lifecycle Product Pricing Considerations Pre-Launch From Exclusivity Period to Landscape in Five Years Based on Indication and State

• Understanding the big picture

• Tactical considerations for process improvements

• Practical examples

Topics that may be covered include:

• Processing claims, bid cycles, best practices for different states
• How manufacturers can best present their products at P&T meetings
• Places of improvement for manufacturer reimbursement/processing claims
• How to work together as states and manufacturers most effectively

Join us for this deep dive workshop into the ever-changing active and pending SPTR laws from the legal and operational perspectives.

• Learn how your peers are addressing SPTR management, operations, and compliance
• Gain more understanding of best practices that you can apply in your organization
• Hear perspectives on future developments

• Tracking legislation and implementing best practices at your company and scaling of efforts
• Privacy hot button issues
• Current litigation review
• What you need to report to what states and what information you need to back it up
• What manufacturers are standing against in SPTR and results

Objectives:

• Discuss elements of the pharmaceutical pricing agreement
• Describe 340B ceiling price calculation
• Identify pricing responsibilities with HRSA and wholesalers

Objectives:

• Understand the guidelines for refunds in the 340B Drug Pricing Program.
• Review the potential reasons necessitating both manufacturer and covered entities to conduct refunds.
• Learn about leading practices, considerations and potential obstacles in the refund process for both manufacturers and covered entities.
• Gain perspectives on good faith inquiries when potential discrepancies are discovered.

Objectives:

• Discuss covered entity inventory management models and purchasing account setups
• Identify contracting methodologies and the procurement activities related to 340B program requirements

Objectives:

• Explain the types of contracts loaded to covered entity purchasing accounts and drivers of purchasing from different accounts
• Identify contracting methodologies and the procurement activities related to 340B program requirements

These one-on-one meetings are scheduled between manufacturers and States to discuss any issues or questions that have come up with rebates and reporting, etc.